Sciwind Biosciences
Biotechnology Research
Hangzhou, Zhejiang Sheng, Cn
8 employees
- Employees
- 8
- Contacts
- 1
- Emails
- 1
Sciwind Biosciences Overview
- Headquarters
- Hangzhou, Zhejiang Sheng, Cn
- Website
- www.sciwindbio.com
- Industry
- Biotechnology Research
- Employees
- 8
- Founded
- 2017
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About Sciwind Biosciences
Sciwind Biosciences is a clinical-stage biopharmaceutical company focused on developing innovative therapies for metabolic diseases. Its lead asset, ecnoglutide (XW003), is currently in the NDA stage in China. Leveraging proprietary platforms for oral peptide and long-acting protein therapeutics, Sciwind has built a diverse pipeline targeting GLP-1 and synergistic mechanisms, offering both injectable and oral treatment options for metabolic pateints worldwide.
Sciwind Biosciences Contact Details
- People in AeroLeads
- 3
- With contact data
- 1
- Email contacts
- 1
- 33.3% coverage
Sciwind Biosciences Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Hai Pan | CEO | China |
Email
|
| Jing Xu, Ph.d | Vice President, Principal |
View
|
|
| Haixia Zou | Drug Discovery |
View
|
Employees by Management Level
Executive
2 profiles
Individual contributor
1 profile
Compare Similar Companies to Sciwind Biosciences
Kailera Therapeutics
Biotechnology Research
Terns Pharmaceuticals
Biotechnology Research
Verdiva Bio
Biotechnology Research
Mediar Therapeutics
Biotechnology Research
MediLink Therapeutics
Biotechnology Research
LYFE Capital
Venture Capital And Private Equity Principals
Viking Therapeutics, Inc.
Pharmaceutical Manufacturing
Tenvie Therapeutics
Biotechnology Research
Starna Therapeutics
Biotechnology
Aiolos Bio
Biotechnology Research